Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 6651       
POLICY DOCUMENT
Year : 2017  |  Volume : 145  |  Issue : 4  |  Page : 448-463

Index-TB guidelines: Guidelines on extrapulmonary tuberculosis for India


1 Department of Internal Medicine, All India Institute of Medical Sciences, New Delhi, India
2 Cochrane Infectious Diseases Group, Liverpool, UK
3 Ministry of Health & Family Welfare, Government of India, New Delhi, India
4 Department of Medicine, Sri Venkateshwara Institute of Medical Sciences, Tirupati, India
5 National Institute of TB & Respiratory Diseases, New Delhi, India
6 Foundation for Innovative New Diagnostics-India & South East Asia, New Delhi, India
7 National Tuberculosis Institute, Bengaluru, India
8 South Asian Cochrane Network & Centre, Vellore, India

Correspondence Address:
Surendra K Sharma
Department of Internal Medicine, All India Institute of Medical Sciences, New Delhi 110 029
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijmr.IJMR_1950_16

Rights and Permissions

Extrapulmonary tuberculosis (EPTB) is frequently a diagnostic and therapeutic challenge. It is a common opportunistic infection in people living with HIV/AIDS and other immunocompromised states such as diabetes mellitus and malnutrition. There is a paucity of data from clinical trials in EPTB and most of the information regarding diagnosis and management is extrapolated from pulmonary TB. Further, there are no formal national or international guidelines on EPTB. To address these concerns, Indian EPTB guidelines were developed under the auspices of Central TB Division and Directorate of Health Services, Ministry of Health and Family Welfare, Government of India. The objective was to provide guidance on uniform, evidence-informed practices for suspecting, diagnosing and managing EPTB at all levels of healthcare delivery. The guidelines describe agreed principles relevant to 10 key areas of EPTB which are complementary to the existing country standards of TB care and technical operational guidelines for pulmonary TB. These guidelines provide recommendations on three priority areas for EPTB: (i) use of Xpert MTB/RIF in diagnosis, (ii) use of adjunct corticosteroids in treatment, and (iii) duration of treatment. The guidelines were developed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria, which were evidence based, and due consideration was given to various healthcare settings across India. Further, for those forms of EPTB in which evidence regarding best practice was lacking, clinical practice points were developed by consensus on accumulated knowledge and experience of specialists who participated in the working groups. This would also reflect the needs of healthcare providers and develop a platform for future research.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed7769    
    Printed42    
    Emailed0    
    PDF Downloaded1317    
    Comments [Add]    

Recommend this journal